Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 894 items for :

  • Refine by access: Content accessible to me x
Clear All
Jennifer R Eads Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Pennsylvania, USA

Search for other papers by Jennifer R Eads in
Google Scholar
PubMed Close
,
Thorvardur R Halfdanarson Division of Medical Oncology, Mayo Clinic Cancer Center, Rochester, Minnesota, USA

Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed Close
,
Tim Asmis Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada

Search for other papers by Tim Asmis in
Google Scholar
PubMed Close
,
Andrew M Bellizzi Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA

Search for other papers by Andrew M Bellizzi in
Google Scholar
PubMed Close
,
Emily K Bergsland Department of Medicine, University of California, San Francisco, California, USA

Search for other papers by Emily K Bergsland in
Google Scholar
PubMed Close
,
Arvind Dasari Division of Gastrointestinal Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Arvind Dasari in
Google Scholar
PubMed Close
,
Ghassan El-Haddad Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Search for other papers by Ghassan El-Haddad in
Google Scholar
PubMed Close
,
Michael Frumovitz Division of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Michael Frumovitz in
Google Scholar
PubMed Close
,
Joshua Meyer Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Search for other papers by Joshua Meyer in
Google Scholar
PubMed Close
,
Erik Mittra Division of Molecular Imaging and Therapy, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Erik Mittra in
Google Scholar
PubMed Close
,
Sten Myrehaug Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Search for other papers by Sten Myrehaug in
Google Scholar
PubMed Close
,
Eric Nakakura Department of Surgery, University of California, San Francisco, California, USA

Search for other papers by Eric Nakakura in
Google Scholar
PubMed Close
,
Nitya Raj Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Nitya Raj in
Google Scholar
PubMed Close
,
Heloisa P Soares Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Salt Lake City, Utah, USA

Search for other papers by Heloisa P Soares in
Google Scholar
PubMed Close
,
Brian Untch Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Brian Untch in
Google Scholar
PubMed Close
,
Namrata Vijayvergia Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Search for other papers by Namrata Vijayvergia in
Google Scholar
PubMed Close
, and
Jennifer A Chan Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jennifer A Chan in
Google Scholar
PubMed Close

Introduction High-grade neuroendocrine neoplasms (NENs) constitute a rare disease entity and account for approximately 10% of all NENs. Given their rarity, there is a paucity of prospective data to guide the optimal diagnosis and management of

Article Type:
Other
DOI:
https://doi.org/10.1530/ERC-22-0206
Volume/Issue:
Volume 30: Issue 8
Open access
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close
,
Oleksii Nikolaienko K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Oleksii Nikolaienko in
Google Scholar
PubMed Close
,
Wei Deng K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Wei Deng in
Google Scholar
PubMed Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed Close
,
Anne Couvelard Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St.Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed Close
,
Merete Krogh Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Merete Krogh in
Google Scholar
PubMed Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed Close

Introduction High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are defined by the presence of neuroendocrine phenotype and a high proliferation rate (Ki-67 > 20%). The HG NEN entity consists of well

Article Type:
Research Article
Collections:
Top-cited articles of 2023
DOI:
https://doi.org/10.1530/ERC-21-0152
Volume/Issue:
Volume 29: Issue 1
Open access
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Sciences, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
,
Grace Kong Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia

Search for other papers by Grace Kong in
Google Scholar
PubMed Close
, and
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close

-term toxicity. 177 Lu-DOTA-octreotate (LuTathera) has recently obtained regulatory approval for patients with progressive metastatic grade 1–2 GEP NET. High-grade gastroenteropancreatic neuroendocrine neoplasms: NET G3 and NEC Gastroenteropancreatic

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0400
Volume/Issue:
Volume 27: Issue 3
Free access
Esben Andreas Carlsen Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark
Department of Biomedical Sciences, Cluster for Molecular Imaging, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Esben Andreas Carlsen in
Google Scholar
PubMed Close
,
Nicola Fazio Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed Close
,
Dan Granberg Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Dan Granberg in
Google Scholar
PubMed Close
,
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, Department of Endocrinology & Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close
,
Hojjat Ahmadzadehfar Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

Search for other papers by Hojjat Ahmadzadehfar in
Google Scholar
PubMed Close
,
Chiara Maria Grana Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Chiara Maria Grana in
Google Scholar
PubMed Close
,
Wouter T Zandee Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Wouter T Zandee in
Google Scholar
PubMed Close
,
Jaroslaw Cwikla Medical School, University of Warmia and Mazury, Olsztyn, Poland

Search for other papers by Jaroslaw Cwikla in
Google Scholar
PubMed Close
,
Martin A Walter Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Search for other papers by Martin A Walter in
Google Scholar
PubMed Close
,
Peter Sandor Oturai Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark

Search for other papers by Peter Sandor Oturai in
Google Scholar
PubMed Close
,
Anja Rinke Department of Gastroenterology, University Hospital Gießen and Marburg, Marburg, Germany

Search for other papers by Anja Rinke in
Google Scholar
PubMed Close
,
Andrew Weaver Department of Oncology, Churchill Hospital, Oxford, UK

Search for other papers by Andrew Weaver in
Google Scholar
PubMed Close
,
Andrea Frilling Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Andrea Frilling in
Google Scholar
PubMed Close
,
Sara Gritti Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Sara Gritti in
Google Scholar
PubMed Close
,
Anne Kirstine Arveschoug Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Kirstine Arveschoug in
Google Scholar
PubMed Close
,
Amichay Meirovitz Department of Oncology and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Amichay Meirovitz in
Google Scholar
PubMed Close
,
Ulrich Knigge Department of Biomedical Sciences, Cluster for Molecular Imaging, University of Copenhagen, Copenhagen, Denmark
Departments of Surgical Gastroenterology and Clinical Endocrinology, Rigshospitalet, Copenhagen, Denmark

Search for other papers by Ulrich Knigge in
Google Scholar
PubMed Close
, and
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close

poorly differentiated high-grade neuroendocrine carcinomas (G3). The terminology of NEN G3 relates to all high-grade (G3, Ki-67 >20%) neuroendocrine malignancies; i.e. both NET G3 and NEC. Gastroenteropancreatic (GEP) NENs G3 are rare, highly malignant

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0424
Volume/Issue:
Volume 26: Issue 2
Free access
Cecile N Chougnet Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Cecile N Chougnet in
Google Scholar
PubMed Close
,
Sophie Leboulleux Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Caroline Caramella Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Caroline Caramella in
Google Scholar
PubMed Close
,
Jean Lumbroso Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Jean Lumbroso in
Google Scholar
PubMed Close
,
Isabelle Borget Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Isabelle Borget in
Google Scholar
PubMed Close
,
Désirée Déandreis Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Désirée Déandreis in
Google Scholar
PubMed Close
,
Pierre Duvillard Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Pierre Duvillard in
Google Scholar
PubMed Close
,
Dominique Elias Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Dominique Elias in
Google Scholar
PubMed Close
,
Thierry de Baere Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Thierry de Baere in
Google Scholar
PubMed Close
,
Fritz-Line Vélayoudom-Céphise Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Fritz-Line Vélayoudom-Céphise in
Google Scholar
PubMed Close
,
Joël Guigay Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Joël Guigay in
Google Scholar
PubMed Close
,
Michel Ducreux Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Michel Ducreux in
Google Scholar
PubMed Close
,
Martin Schlumberger Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
, and
Eric Baudin Departments of Nuclear Medicine and Endocrine Tumors, Medical Imaging, Biostatistics and Epidemiology, Pathology, Oncologic Surgery, Department of Endocrinology, Departments of Medical Oncology, Digestive Oncology

Search for other papers by Eric Baudin in
Google Scholar
PubMed Close

or PET status ( Garin et al . 2009 , Binderup et al . 2010 a ). More precisely, high-grade of SRS uptake was recently found to carry prognostic information ( Imhof et al . 2011 ). However, in the absence of randomized study, the respective

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0169
Volume/Issue:
Volume 20: Issue 2
Free access
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed Close
,
Aurel Perren Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed Close
,
Anne Couvelard Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St. Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed Close
,
Lene W Vestermark Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Lene W Vestermark in
Google Scholar
PubMed Close
,
Morten Ladekarl Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Morten Ladekarl in
Google Scholar
PubMed Close
,
Elizaveta Mitkina Tabaksblat Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by Elizaveta Mitkina Tabaksblat in
Google Scholar
PubMed Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed Close

Introduction Neuroendocrine neoplasms (NENs) constitute ~2% of all malignancies and are frequently located in the gastrointestinal (GI) tract and pancreas. High-grade gastroenteropancreatic (HG-GEP) NENs are among the most aggressive cancers

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0057
Volume/Issue:
Volume 30: Issue 10
Open access
Alicia A Tone The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Alicia A Tone in
Google Scholar
PubMed Close
,
Carl Virtanen The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Carl Virtanen in
Google Scholar
PubMed Close
,
Patricia A Shaw The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Patricia A Shaw in
Google Scholar
PubMed Close
, and
Theodore J Brown The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9
The Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Department of Obstetrics and Gynecology, Department of Pathology, Microarray Centre, Mount Sinai Hospital, University of Toronto, 60 Murray Street, PO Box 41, Toronto, Ontario, Canada M5T 3L9

Search for other papers by Theodore J Brown in
Google Scholar
PubMed Close

epithelium (OSE), accumulating evidence provides strong support that high-grade serous adnexal cancer, commonly attributed to an ovarian origin, arises from the distal fallopian tube epithelium (FTE; Colgan et al . 2001 , Piek et al . 2001 , Finch et al

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-10-0235
Volume/Issue:
Volume 18: Issue 2
Open access
View license
Zhigang Zhao Department of Urology of Minimally Invasive Surgery Center, the First Affiliated Hospital of Guangzhou Medical College, No. 1–3, Kangda Road, Guangzhou 510230, Guangdong Province, People's Republic of China

Search for other papers by Zhigang Zhao in
Google Scholar
PubMed Close
and
Guohua Zeng Department of Urology of Minimally Invasive Surgery Center, the First Affiliated Hospital of Guangzhou Medical College, No. 1–3, Kangda Road, Guangzhou 510230, Guangdong Province, People's Republic of China

Search for other papers by Guohua Zeng in
Google Scholar
PubMed Close

Introduction High-grade prostatic intraepithelial neoplasia (HGPIN) is currently accepted as a risk factor for the delayed progression to prostate cancer (PCa; Dovey et al . 2005 , Ayala & Ro 2007 , Chin et al . 2007 , Montironi et al . 2007

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-10-0017
Volume/Issue:
Volume 17: Issue 2
Free access
Philippe L Bedard
Search for other papers by Philippe L Bedard in
Google Scholar
PubMed Close
,
Sandeep K Singhal Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Sandeep K Singhal in
Google Scholar
PubMed Close
,
Michail Ignatiadis Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Michail Ignatiadis in
Google Scholar
PubMed Close
,
Ian Bradbury Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Ian Bradbury in
Google Scholar
PubMed Close
,
Benjamin Haibe-Kains Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Benjamin Haibe-Kains in
Google Scholar
PubMed Close
,
Christine Desmedt Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Christine Desmedt in
Google Scholar
PubMed Close
,
Sherene Loi Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Sherene Loi in
Google Scholar
PubMed Close
,
Dean B Evans Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Dean B Evans in
Google Scholar
PubMed Close
,
Stefan Michiels Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Stefan Michiels in
Google Scholar
PubMed Close
,
J Michael Dixon Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by J Michael Dixon in
Google Scholar
PubMed Close
,
William R Miller Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by William R Miller in
Google Scholar
PubMed Close
,
Martine J Piccart Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Martine J Piccart in
Google Scholar
PubMed Close
, and
Christos Sotiriou Division of Medical Oncology and Hematology, Breast Cancer Translational Research Laboratory JC Heuson, Frontier Science (Scotland) Ltd, School of Medicine, Machine Learning Group, Novartis Institutes for BioMedical Research, Breakthrough Breast Research Group, University of Edinburgh, Department of Biostatistics and Computational Biology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Christos Sotiriou in
Google Scholar
PubMed Close

genomic grade and high genomic grade tumors, with long-term outcomes that resemble low and high histological grade tumors in the absence of systemic therapy ( Sotiriou et al . 2006 ). At least, four distinct clinically relevant molecular subtypes of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-11-0180
Volume/Issue:
Volume 18: Issue 6
Free access
Florian Bösch Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Florian Bösch in
Google Scholar
PubMed Close
,
Katharina Brüwer Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Katharina Brüwer in
Google Scholar
PubMed Close
,
Annelore Altendorf-Hofmann Department of General, Visceral und Vascular Surgery, Friedrich-Schiller University, Jena, Germany

Search for other papers by Annelore Altendorf-Hofmann in
Google Scholar
PubMed Close
,
Christoph J Auernhammer Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Christoph J Auernhammer in
Google Scholar
PubMed Close
,
Christine Spitzweg Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Christine Spitzweg in
Google Scholar
PubMed Close
,
C Benedikt Westphalen Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by C Benedikt Westphalen in
Google Scholar
PubMed Close
,
Stefan Boeck Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Stefan Boeck in
Google Scholar
PubMed Close
,
Gabriele Schubert-Fritschle Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Gabriele Schubert-Fritschle in
Google Scholar
PubMed Close
,
Jens Werner Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Jens Werner in
Google Scholar
PubMed Close
,
Volker Heinemann Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Volker Heinemann in
Google Scholar
PubMed Close
,
Thomas Kirchner Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany

Search for other papers by Thomas Kirchner in
Google Scholar
PubMed Close
,
Martin Angele Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Martin Angele in
Google Scholar
PubMed Close
, and
Thomas Knösel Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany

Search for other papers by Thomas Knösel in
Google Scholar
PubMed Close

1.6 Correlation between TILs, PD-1 and PD-L1 expression and grading High TILs (≥3 lymphocytes per TMA-spot) could be evaluated in 47 cases (19.6%). High PD-1 expression in TILs was seen in 35 samples (16.1%), and 20 samples (8

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0494
Volume/Issue:
Volume 26: Issue 3
Free access